"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

On Worlds AIDS Day, the benefits of PEPFAR, PrEP, and U=U are celebrated. But continuing stigma and decreasing political will ...

Considerable scale-up is needed to achieve the 2025 goals for HIV pre-exposure prophylaxis (PrEP), according to study findings.

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...

Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

Remarkable progress has been made against the HIV epidemic in the last two decades. However, a loss of momentum in fighting ...

But Woodward said the increase could be slowed down if there was greater uptake in drugs that prevent HIV transmission, ...